K Number
K190002
Device Name
Sterile Hypodermic Syringe for Single use, with/without needle, Sterile Insulin Syringe for Single use, with needle, Sterile Hypodermic needle for Single use
Date Cleared
2019-09-12

(253 days)

Product Code
Regulation Number
880.5860
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The sterile Hypodermic Syringe for Single use, with/without needle is intended to be used for medical purposes to inject fluid into or withdraw fluid from body. The sterile Insulin Syringe for Single use with needle, with the callbration unit of insulin for U-100, is a device intended for medical purposes for the manual aspiration of insulin into parts of insulin into parts of insulin into parts of the body below the surface skin. The sterile Insulin Syringe for Single use with the callbration unit of insulin for U-40, is a device intended for medical purposes for the manual aspiration of insulin into parts of insulin into parts of insulin into parts of the body below the surface skin. The sterile Hypodermic needle for Single use is intended for use with syringes and injection devices for general purpose fluid injection/aspiration.
Device Description
The plunger of syringe can be pulled and pushed along inside the barrel, allowing the syringe to take in and expel the fluids through the connector to the patient. Configuration: Piston, Plunger, Barrel, (Needle) for Hypodermic Syringe; Needle cover, Needle, Piston, Barrel, Plunger, End cap for Insulin Syringe; Protective cap, Needle tube, Adhesives, Needle hub for Hypodermic Needle. Operation Mode: For manual use only. Nozzle: Luer Slip, Luer Lock for Hypodermic Syringe and Hypodermic Needle; Fixed Needle for Insulin Syringe. Volume/Sizes: Luer slip: 1,2,3,5,10,20,30,35,50,60(ml), Luer Lock: 1,2,3,5,10,20,30,35,50,60(ml), 18G, 19G, 20G, 21G, 22G, 23G, 24G, 25G, 26G, 27G, 28G, 29G, 30G for Hypodermic Syringe; 0.3, 0.5, 1(ml), 29G, 30G, 31G for Insulin Syringe; 18G, 19G, 20G, 21G, 22G, 23G, 24G, 25G, 26G, 27G, 28G, 29G, 30G for Hypodermic Needle. Material: Plunger: polypropylene (PP); Barrel: polypropylene (PP); Piston: isoprene rubber; Hypodermic needle: polypropylene (PP), stainless steel; for Hypodermic Syringe; Needle cover: polypropylene (PP); Needle: stainless steel (SUS); Piston: isoprene rubber; Barrel: polypropylene (PP); Plunger: polypropylene (PP); End cap: polypropylene (PP); for Insulin Syringe; Protective cap: polypropylene (PP), Needle tube: stainless steel (SUS), Adhesives: epoxy resin, Needle hub: polypropylene (PP) for Hypodermic Needle.
More Information

Not Found

No
The device description explicitly states "Operation Mode: For manual use only" and there is no mention of AI, ML, image processing, or any computational analysis of data. The performance studies are limited to bench tests and biocompatibility, not algorithmic performance.

No.
The device is used to inject or withdraw fluids, including insulin, from the body. While it facilitates the administration of therapeutic substances, the device itself is a delivery mechanism and does not directly provide therapy or treatment.

No

The device, which includes hypodermic syringes and needles, is intended for injecting or withdrawing fluids (including insulin) from the body. Its function is to facilitate the delivery or removal of substances, not to diagnose a medical condition or provide information about a disease.

No

The device description clearly outlines physical components like plungers, barrels, needles, and pistons, indicating it is a hardware device.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly states that the devices are for injecting or withdrawing fluids from the body, or for the manual aspiration of insulin into the body. This involves direct interaction with the patient's body.
  • IVD Definition: In vitro diagnostics are devices intended for use in the examination of specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This examination happens outside the body (in vitro).
  • Device Description: The description details the physical components and operation of syringes and needles, which are tools for administering or collecting substances from or into the body, not for analyzing specimens.
  • Lack of IVD-related information: There is no mention of analyzing samples, reagents, or any processes typically associated with in vitro diagnostics.

The devices described are medical devices used for therapeutic or diagnostic procedures involving the patient's body directly, not for in vitro analysis of specimens.

N/A

Intended Use / Indications for Use

The sterile Hypodermic Syringe for Single use, with/without needle is intended to be used for medical purposes to inject fluid into or withdraw fluid from body.

The sterile Insulin Syringe for Single use with needle, with the callbration unit of insulin for U-100, is a device intended for medical purposes for the manual aspiration of insulin into parts of insulin into parts of insulin into parts of the body below the surface skin.

The sterile Insulin Syringe for Single use with the callbration unit of insulin for U-40, is a device intended for medical purposes for the manual aspiration of insulin into parts of insulin into parts of insulin into parts of the body below the surface skin.

The sterile Hypodermic needle for Single use is intended for use with syringes and injection devices for general purpose fluid injection/aspiration.

Product codes

FMF, FMF, FMI

Device Description

The subject device is comprised of three types of products:

  1. Sterile Hypodermic Syringe for Single use, with/without needle:

    • Principle of Operation: The plunger of syringe can be pulled and pushed along inside the barrel, allowing the syringe to take in and expel the fluids through the connector to the patient.
    • Operation Mode: For manual use only
    • Configuration: Piston, Plunger, Barrel, (Needle)
    • Nozzle: Luer Slip, Luer Lock
    • Volume/Sizes: Luer slip: 1,2,3,5,10,20,30,35,50,60 (ml); Luer Lock: 1,2,3,5,10,20,30,35,50,60 (ml); 18G, 19G, 20G, 21G, 22G, 23G, 24G, 25G, 26G, 27G, 28G, 29G, 30G
    • Material: Plunger: polypropylene (PP); Barrel: polypropylene (PP); Piston: isoprene rubber; Hypodermic needle: polypropylene (PP), stainless steel;
  2. Sterile Insulin Syringe for Single use, with needle:

    • Principle of Operation: The plunger of syringe can be pulled and pushed along inside the barrel, allowing the syringe to take in and expel the fluids through the connector to the patient.
    • Operation Mode: For manual use only
    • Configuration: Needle cover; Needle; Piston; Barrel; Plunger; End cap
    • Nozzle: Fixed Needle
    • Volume/Sizes: 0.3,0.5,1 (ml); 29G, 30G, 31G
    • Material: Needle cover: polypropylene (PP); Needle: stainless steel (SUS); Piston: isoprene rubber; Barrel: polypropylene (PP); Plunger: polypropylene (PP); End cap: polypropylene (PP);
  3. Sterile Hypodermic needle for Single use:

    • Principle of Operation: The plunger of syringe can be pulled and pushed along inside the barrel, allowing the syringe to take in and expel the fluids through the connector to the patient. (Note: This is likely a copy-paste error from the syringe descriptions. The principle of operation for a needle would involve fluid flow through its lumen when attached to an injection device).
    • Operation Mode: For manual use only
    • Configuration: Protective cap; Needle tube; Adhesives; Needle hub;
    • Nozzle: Luer Slip, Luer Lock
    • Volume/Sizes: 18G, 19G, 20G, 21G, 22G, 23G, 24G, 25G, 26G, 27G, 28G, 29G, 30G
    • Material: Protective cap: polypropylene (PP); Needle tube: stainless steel (SUS); Adhesives: epoxy resin; Needle hub: polypropylene (PP)
    • Detailed specifications include needle gauge and needle wall (TW/RW) for various sizes.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Body (for injection/withdrawal of fluid); parts of the body below the surface skin (for insulin injection).

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Sterile Hypodermic Syringe for Single use, with/without needle, Sterile Hypodermic needle for Single use: Medical professionals and trained care givers, Hospital environment.
Sterile Insulin Syringe for Single use, with needle: Patient use, Home use (OTC).

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Bench tests were conducted to verify that the proposed device met all design specifications and is Substantially Equivalent (SE) to the predicate devices.
The test results demonstrated that the proposed device complies with the following standards:

  • For Sterile Hypodermic Syringe for single use, with/without needle: ISO 7886-1:2017, ISO 594-1:1986, ISO 594-2:1998.
  • For Sterile Insulin Syringe for single use, with needle: ISO 8537:2016, ISO 594-1:1986, ISO 594-2:1998.
  • For Sterile Hypodermic Needle for single use: ISO 7864:2017, ISO 9626:2016, ISO 594-1:1986, ISO 594-2:1998.

Sterilization and package integrity evaluation: ISO 11135:2014, ISO 10993-7:2008, USP39-NF34 , ASTM F88/F88M-15, ASTM F1929-15.
Accelerated aging testing was conducted to substantiate the 5 year shelf life.
Biocompatibility tests performed per ISO 10993-1: Cytotoxicity, Irritation, Sensitization, Material Mediated Pyrogenicity, Acute Systemic Toxicity.
Particulates per USP .
Key results: The devices met the requirements of the standards specified. The 60ml syringe model, which was not in the predicate, met the requirements of ISO 7886-1. The proposed device was demonstrated to be Substantially Equivalent (SE) to the predicate device K112057.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K112057

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 880.5860 Piston syringe.

(a)
Identification. A piston syringe is a device intended for medical purposes that consists of a calibrated hollow barrel and a movable plunger. At one end of the barrel there is a male connector (nozzle) for fitting the female connector (hub) of a hypodermic single lumen needle. The device is used to inject fluids into, or withdraw fluids from, the body.(b)
Classification. Class II (performance standards).

0

Image /page/0/Picture/0 description: The image shows the logo for the U.S. Food & Drug Administration (FDA). The logo consists of two parts: a symbol on the left and the FDA name on the right. The symbol is a stylized representation of a human figure, while the FDA name is written in blue and includes the words "U.S. Food & Drug Administration".

September 12, 2019

Shanghai Kohope Medical Devices Co., Ltd % Diana Hong Hong General Manager Mid-Link Consulting Co., Ltd P.O. Box 120-119 Shanghai, 200120 Cn

Re: K190002

Trade/Device Name: Sterile Hypodermic Syringe for Single use, with/without needle, Sterile Insulin Syringe for Single use, with needle, Sterile Hypodermic needle for Single use Regulation Number: 21 CFR 880.5860 Regulation Name: Piston Syringe Regulatory Class: Class II Product Code: FMF, FMF, FMI Dated: July 28, 2019 Received: August 9, 2019

Dear Diana Hong Hong:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

1

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely.

For CAPT Alan M. Stevens Assistant Director DHT3C: Division of Drug Delivery and General Hospital Devices, and Human Factors OHT3: Office of Gastrorenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K190002

Device Name

Sterile Hypodermic Syringe for Single use, with/without needle

Indications for Use (Describe)

The sterile Hypodermic Syringe for Single use, with/without needle is intended to be used for medical purposes to inject fluid into or withdraw fluid from body.

Type of Use (Select one or both, as applicable)

X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

Indications for Use

510(k) Number (if known) K190002

Device Name

Sterile Insulin Syringe for Single use, with needle

Indications for Use (Describe)

The sterile Insulin Syringe for Single use with needle, with the callbration unit of insulin for U-100, is a device intended for medical purposes for the manual aspiration of insulin into parts of insulin into parts of insulin into parts of the body below the surface skin.

The sterile Insulin Syringe for Single use with the callbration unit of insulin for U-40, is a device intended for medical purposes for the manual aspiration of insulin into parts of insulin into parts of insulin into parts of the body below the surface skin.

Type of Use (Select one or both, as applicable)
---------------------------------------------------

Prescription Use (Part 21 CFR 801 Subpart D)

|X | Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

4

Indications for Use

510(k) Number (if known)

Device Name

Sterile Hypodermic needle for Single use

Indications for Use (Describe)

The sterile Hypodermic needle for Single use is intended for use with syringes and injection devices for general purpose fluid injection/aspiration.

Type of Use (Select one or both, as applicable)

X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

5

K190002 510(k) Summary

This 510(k) Summary is being submitted in accordance with requirements of Title 21, CFR Section 807.92.

    1. Date of Preparation: 09/11/2019
    1. Sponsor Identification

SHANGHAI KOHOPE MEDICAL DEVICES CO., LTD.

Room 1001, No.2 building, Lane 2888, South Qilian Mountains Road, Putuo District, Shanghai, 200331, China

Establishment Registration Number: Not yet registered

Contact Person: Yibing Wang Position: General Manager Tel: +86-021-60836369 Email: 871830973@qq.com

    1. Designated Submission Correspondent
      Ms. Diana Hong (Primary Contact Person) Mr. Chengyu Wang (Alternative Contact Person)

Mid-Link Consulting Co., Ltd

P.O. Box 120-119, Shanghai, 200120, China

Tel: +86-21-22815850, Fax: 3609253199 Email: info@mid-link.net

6

  • Subject Device 4.
    • Trade Name: Sterile Hypodermic Syringe for Single use, with/without needle a. Classification: II Regulation Name: Piston Syringe Regulation Number: 21 CFR 880.5860 Common Name: Syringe, Piston Product Code: FMF
    • b. Trade Name: Sterile Insulin Syringe for Single use, with needle Classification: II Regulation Name: Piston Syringe Regulation Number: 21 CFR 880.5860 Common Name: Syringe, Piston Product Code: FMF
    • Trade Name: Sterile Hypodermic needle for Single use c. Classification: II Regulation Name: Hypodermic single lumen needle Regulation Number: 21 CFR 880.5570 Common Name: Needle, Hypodermic, Single Lumen Product Code: FMI
  • న్. Identification of Predicate Device 510(k) Number: K112057 Product Name: Sterile Hypodermic Syringe for Single use with/ without Needle, Sterile Hypodermic Needle for Single use, Sterile Insulin Syringe for Single use with Needle (U-40), Sterile Insulin Syringe for Use with Needle (U-100) Manufacturer: Shanghai Kindly Enterprise Development Group Co., Ltd.

7

6. Device Description
Device NameSterile Hypodermic Syringe
for Single Use with/without
NeedleSterile Insulin Syringe for
single use with NeedleSterile Hypodermic
Needle for single use
Intended UseThe Sterile Hypodermic Syringe for Single Use with/without Needle is intended to be used for medical purposes to inject fluid into or withdraw fluid from body.The sterile insulin syringe for single use with needle, with the calibration unit of insulin for U-100, is a device intended for medical purposes for the manual aspiration of insulin, and for the injection of insulin into parts of the body below the surface skin.
The sterile insulin syringe for single use with needle, with the calibration unit of insulin for U-40 is a device intended for medical purposes for the manual aspiration of insulin, and for the injection of insulin into parts of the body below the surface skin.The Sterile Hypodermic Needle for single use is intended for use with syringes and injection devices for general purpose fluid injection/aspiration
Principle of
OperationThe plunger of syringe can be pulled and pushed along inside the barrel, allowing the syringe to take in and expel the fluids through the connector to the patient.The plunger of syringe can be pulled and pushed along inside the barrel, allowing the syringe to take in and expel the fluids through the connector to the patient.The plunger of syringe can be pulled and pushed along inside the barrel, allowing the syringe to take in and expel the fluids through the connector to the patient.
Operation ModeFor manual use onlyFor manual use onlyFor manual use only
ConfigurationPiston
Plunger
Barrel
(Needle)Needle cover;
Needle;
Piston;
Barrel;
Plunger;
End capProtective cap;
Needle tube;
Adhesives;
Needle hub;
NozzleLuer Slip, Luer LockFixed NeedleLuer Slip, Luer Lock
Volume/SizesLuer slip:
1,2,3,5,10,20,30,35,50,60(ml)0.3,0.5,1(ml)
29G, 30G, 31G18G, 19G, 20G, 21G,
22G, 23G, 24G, 25G
Device NameSterile Hypodermic Syringe
for Single Use with/without
NeedleSterile Insulin Syringe for
single use with NeedleSterile Hypodermic
Needle for single use
Luer Lock:
1,2,3,5,10,20,30,35,50,60(ml)
18G, 19G, 20G, 21G, 22G,
23G, 24G, 25G, 26G, 27G,
28G, 29G, 30G26G, 27G, 28G, 29G,
30G
MaterialPlunger: polypropylene (PP);
Barrel: polypropylene (PP);
Piston: isoprene rubber;
Hypodermic
needle:
polypropylene (PP), stainless
steel;Needle cover: polypropylene
(PP);
Needle: stainless steel (SUS);
Piston: isoprene rubber;
Barrel: polypropylene (PP);
Plunger: polypropylene (PP);
End cap: polypropylene (PP);Protective
cap:
polypropylene (PP)
Needle tube: stainless
steel (SUS)
Adhesives:
epoxy
resin:
Needle
hub:
polypropylene (PP)

6. Device Description

8

Detailed specifications of the Sterile Hypodermic Needle for single use:

Product SpecificationNeedle GaugeNeedle wall
1.2 mm TW x38mm18GTW
1.1 mm TWx38mm19GTW
0.9 mm TWx38mm20GTW
0.8 mm TWx50mm21GTW
0.7 mm TWx38mm22GTW
0.6 mm TWx32mm23GTW
0.55 mm TWx25mm24GTW
0.55 mm RWx20mm24GRW
0.5 mm TWx25mm25GTW
0.5 mm RWx20mm25GRW
0.45 mm RWx16mm26GRW
0.4 mm RWx13mm27GRW
0.36 mm RWx8mm28GRW
0.33 mm RWx6mm29GRW
0.3 mm RWx4mm30GRW

9

7. Indications For Use

Sterile Hypodermic Syringe for Single Use, With/without Needle:

The sterile Hypodermic Syringe for Single use, with/without needle is intended to be used for medical purposes to inject fluid into or withdraw fluid from body.

Sterile Insulin Syringe for Single use, with Needle:

The sterile Insulin Syringe for Single use with needle, with the calibration unit of insulin for U-100, is a device intended for medical purposes for the manual aspiration of insulin, and for the injection of insulin into parts of the body below the surface skin.

The sterile Insulin Syringe for Single use with needle, with the calibration unit of insulin for U-40, is a device intended for medical purposes for the manual aspiration of insulin, and for the injection of insulin into parts of the body below the surface skin.

Sterile Hypodermic needle for Single Use:

The sterile Hypodermic needle for Single use is intended for use with syringes and injection devices for general purpose fluid injection/aspiration.

8. Substantially Equivalent (SE) Comparison

Needle
ITEMSubject DevicePredicate Device
K112057Comparison
Product nameSterile Hypodermic Syringe
for Single use, with/without
needleSterile Hypodermic Syringe
for Single use, with/without
needle
Product codeFMFFMFSame
Regulation No.21 CFR 880.586021 CFR 880.5860Same
ClassIIIISame
Indications for useThe Sterile Hypodermic
Syringe for Single Use
with/without needle is
intended to be used for
medical purposes to inject
fluid into or withdraw fluid
from body.The Sterile Hypodermic
Syringe for Single Use
with/without needle is
intended to be used for
medical purposes to inject
fluid into or withdraw fluid
from body.Same
ConfigurationPiston
Plunger
BarrelPiston
Plunger
BarrelSame

Table 1 Comparison of Technology Characteristics of Sterile Hypodermic Syringe for Single Use, with/without

10

Sterility conditionEO SterilizedEO SterilizedSame
Environment of useHospitalHospitalSame
Intended usersMedical professionals and trained care giversMedical professionals and trained care giversSame
Single useYesYesSame
Operation modeFor Manual Use Only, For Single Use onlyFor Manual Use Only, For Single Use onlySame
Label/labelingComplied with 21 CFR part 801Complied with 21 CFR part 801Same
Product performanceComplied with
ISO 7886-1
ISO 7864
ISO 9626Complied with
ISO 7886-1
ISO 7864
ISO 9626Same
Volume1ml, 3ml, 5ml, 6ml, 10ml, 20ml, 30ml, 35ml, 50ml and 60 ml1ml, 3ml, 5ml, 6ml, 10ml, 20ml, 30ml, 35ml and 50mlDifferent; the subject
device includes a 60 mL
model
Sizes18G,19G,20G,21G,22G,23G,
24G,25G,26G,27G,28G,29G,
30G18G,19G,20G,21G,22G,23G,
24G,25G,26G,27G,28G,29G,
30GSame
Needle Lengths4–38 mmNot providedSame
Patient contact component and material
PistonIsoprene RubberIsoprene RubberSame
BarrelPPPPSame
PlungerPPPPSame
NeedlePP, SUS304PP, SUS304Same
Sterilization
SAL10-610-6Same
Endotoxin Limit20 EU per device20 EU per deviceSame
ITEMSubject DevicePredicate Device
K112057Comparison
Product nameSterile Insulin Syringe for
Single use, with needleSterile Insulin Syringe for
Single use, with needleSame
Product codeFMFFMFSame
Regulation No.21 CFR 880.586021 CFR 880.5860Same
ClassIIIISame
Indications for useThe sterile insulin syringe
for single use with needle,
with the calibration unit of
insulin for U-100, is a
device intended for medical
purposes for the manual
aspiration of insulin, and for
the injection of insulin into
parts of the body below the
surface skin.The sterile insulin syringe
for single use with needle,
with the calibration unit of
insulin for U-100, is a
device intended for medical
purposes for the manual
aspiration of insulin, and for
the injection of insulin into
parts of the body below the
surface skin.Same
The sterile insulin syringe
for single use with needle,
with the calibration unit of
insulin for U-40 is a device
intended for medical
purposes for the manual
aspiration of insulin, and for
the injection of insulin into
parts of the body below the
surface skin.The sterile insulin syringe
for single use with needle,
with the calibration unit of
insulin for U-40 is a device
intended for medical
purposes for the manual
aspiration of insulin, and for
the injection of insulin into
parts of the body below the
surface skin.
ConfigurationNeedle CapNeedle CapSame
NeedleNeedle
PistonPiston
BarrelBarrel
PlungerPlunger
End CapEnd Cap
Sterility conditionEO SterilizedEO SterilizedSame
Environment
of
useHome use (OTC)Home use (OTC)Same
Intended usersPatient usePatient useSame
Single useYesYesSame
Operation modeFor Manual Use Only, ForFor Manual Use Only, ForSame
Single Use onlySingle Use only
Label/labelingComplied with 21 CFR partComplied with 21 CFR partSame
801801
Product performanceComplied with ISO 8537Complied with ISO 8537Same
Volume0.3ml, 0.5ml, 1ml volumes
with fixed needle0.3ml, 0.5ml, 1ml volumes
with fixed needleSame
Needle lengths8mm, 13mmNot providedSame
Patient contact component and material
PistonIsoprene RubberIsoprene RubberSame
BarrelPPPPSame
PlungerPPPPSame
Needle CoverPPPPSame
NeedleStainless Steel (SUS304)Stainless Steel (SUS304)Same
End CapPPPPSame
Sterilization
SAL10-610-6Same
Endotoxin Limit20 EU per device20 EU per deviceSame

Discussion:

The indications for use statement for the subject device is identical to the predicate device.

The there are no technological differences between the predicate and subject devices for the 1 – 50 mL syringes and the hypodermic needles. This was verified by performance testing per ISO 7886-1, ISO 7864, and ISO 9626. The subject device includes a 60 ml syringe size not included in the predicate. However, performance testing to ISO 7886-1 has been conducted on this model and demonstrates that the 60ml syringe meets the requirements of the standard. The hypodermic needles were shown to comply with ISO 7864 and ISO 9626.

11

12

Discussion:

The indications for use statement for the subject device is identical to the predicate device. There are no technological differences between the subject and the predicate device. This was verified by performance testing to ISO 8537. The intended use, principle of operation, materials, specification information for the subject device are the same as for the predicate device. Therefore, it can be determined that the proposed device is substantially equivalent to the predicate device.

ITEMSubject DevicePredicate DeviceComparison
Product nameSterile Hypodermic needle for Single useSterile Hypodermic needle for Single use
Product codeFMIFMISame
Regulation No.21 CFR 880.557021 CFR 880.5570Same
ClassIIIISame
Indications for useThe Sterile Hypodermic Needle for single use is intended for use with syringes and injection devices for general purpose fluid injection/aspiration.The Sterile Hypodermic Needle for single use is intended for use with syringes and injection devices for general purpose fluid injection/aspiration.Same
ConfigurationProtective cap
Needle tubeProtective cap
Needle tubeSame

Table 3 Comparison of Technology Characteristics of Sterile Hypodermic Needle for Single Use

13

| | Adhesives
Needle hub | Adhesives
Needle hub | |
|----------------------------------------|-------------------------------------------------------------|-------------------------------------------------------------|------|
| Sterility
condition | EO Sterilized | EO Sterilized | Same |
| Environment of
use | Hospital | Hospital | Same |
| Intended users | Medical professionals and
trained care givers | Medical professionals and
trained care givers | Same |
| Single use | Yes | Yes | Same |
| Operation mode | For Manual Use Only, For
Single Use only | For Manual Use Only, For
Single Use only | Same |
| Label/labeling | Complied with 21 CFR part
801 | Complied with 21 CFR part
801 | Same |
| Product
performance | Complied with:
ISO 7864
ISO 9626 | Complied with:
ISO 7864
ISO 9626 | Same |
| Gauges | 18G,19G,20G,21G,22G,23G,
24G,25G,26G,27G,28G,29G,
30G | 18G,19G,20G,21G,22G,23G,
24G,25G,26G,27G,28G,29G,
30G | Same |
| Needle lengths | 4 – 38 mm | Not provided | Same |
| Patient contact component and material | | | |
| Protective cap | PP | PP | Same |
| Needle tube | Stainless steel (SUS304) | Stainless steel (SUS304) | Same |
| Adhesives | Epoxy resin | Epoxy resin | Same |
| Needle hub | PP | PP | Same |
| Sterilization | | | |
| SAL | 10-6 | 10-6 | Same |
| Endotoxin Limit | 20 EU per device | 20 EU per device | Same |

Discussion:

The indications for use statement for the subject device is identical to the predicate device.

There are no technological differences between the subject and the predicate device. This was verified by performance testing according to ISO 7864 and ISO 9626. The intended use, principle of operation, materials, specifications and sterilization information for the subject device are the same as for the predicate device. Therefore, it can be determined that the proposed device is substantially equivalent to the predicate device.

9. Non-Clinical Testing

Bench tests were conducted to verify that the proposed device met all design specifications and is Substantially Equivalent (SE) to the predicate devices. The test results demonstrated that the proposed device complies with the following standards:

14

  • For Sterile Hypodermic Syringe for single use, with/without needle a.
    ISO 7886-1:2017 Sterile Hypodermic Syringes for Single Use - Part 1: Syringes for Manual Use. ISO 594-1:1986, Conical Fittings with A 6% (Luer) Taper for Syringes, Needles and Certain Other Medical Equipment - Part 1: General Requirements. ISO 594-2:1998 Conical Fittings with A 6% (Luer) Taper for Syringes, Needles and Certain Other Medical Equipment - Part 2: Lock Fittings.

  • b. For Sterile Insulin Syringe for single use, with needle
    ISO 8537:2016 Sterile single-use syringes, with or without needle. for insulin; ISO 594-1:1986, Conical Fittings with A 6% (Luer) Taper for Syringes, Needles and Certain Other Medical Equipment - Part 1: General Requirements. ISO 594-2:1998 Conical Fittings with A 6% (Luer) Taper for Syringes, Needles and Certain Other Medical Equipment - Part 2: Lock Fittings.

  • c. For Sterile Hypodermic Needle for single use
    ISO 7864:2017, Sterile Hypodermic Needles for Single Use.

ISO 9626:2016 Stainless steel needle tubing for the manufacture of medical devices - Requirements and test methods

ISO 594-1:1986, Conical Fittings with A 6% (Luer) Taper for Syringes. Needles and Certain Other Medical Equipment - Part 1: General Requirements.

ISO 594-2:1998 Conical Fittings with A 6% (Luer) Taper for Syringes, Needles and Certain Other Medical Equipment - Part 2: Lock Fittings.

The following standards are used to evaluate the sterilization and package integrity. The test results show that the proposed device complies with the requirements.

ISO 11135:2014 Sterilization of health care products - Ethylene oxide - Requirements for development, validation and routine control of a sterilization process for medical devices;

ISO 10993-7:2008 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals;

USP39-NF34 Bacterial Endotoxin Limit

ASTM F88/F88M-15 standard test method for seal strength of flexible barrier materials;

ASTM F1929-15 Standard test method for detecting seal leaks in porous medical packaging by dye penetration

In addition, accelerated aging testing was conducted to substantiate the 5 year shelf life of the proposed device.

Biocompatibility

The devices were tested for biocompatibility per ISO 10993-1 Biological evaluation of medical devices – Part

15

1 : Evaluation and testing within a risk management process. The following tests were performed: Cytotoxicity, Irritation, Sensitization, Material Mediated Pyrogenicity, Acute Systemic Toxicity, In addition, the subject devices were tested for particulates per USP .

    1. Clinical Test Conclusion
      No clinical study is included in this submission.
    1. Substantially Equivalent (SE) Conclusion
      The proposed device, Sterile Hypodermic Syringe for single use, with/without needle, Sterile Insulin Syringe for single use with needle and Sterile Hypodermic Needle for single use, were demonstrated to be Substantially Equivalent (SE) to the predicate device K112057.